Stroke - Cell La Vie

07Sepseptembre 7, 2026

MSC Therapy for Ischemic Stroke: What a 2026 Umbrella Review and Network Meta-Analysis of 1,006 Patients Reveal

The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce mortality. This medical review synthesizes the latest clinical data, mechanisms, active trials, and translational barriers.

MSC, Cellules souches, Accident vasculaire cérébralessai clinique, immune system, Immunomodulation des CSM, MSC therapy, msc, médecine régénérative, cellule souche, cellules souches

19Juinjuin 19, 2026

Intravenous UC-MSCs for Ischemic Stroke: What the MERIT Phase 1 Trial Tells Us

The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.

MSC, Cellules souches, Accident vasculaire cérébralimmune system, mésenchymateux, MSC clinical outcomes, msc, médecine régénérative, cellule souche, cellules souches, stem cells Thailand0 Commentaires

17Févfévrier 17, 2025

Stem Cell Therapy ‘Jump-Starts’ Brain Repair After Stroke: A New Era in Neurological Recovery

Imagine a world where the devastating effects of a stroke could be reversed, even weeks after the event. This isn’t science fiction—it’s the promising reality emerging from groundbreaking research in stem cell therapy. A recent study has shown that stem cell treatment can effectively ‘jump-start’ brain repair processes, offering new...

Cellules souches, Accident vasculaire cérébral0 Commentaires

Haut